SARS-CoV-2 replicon for high-throughput antiviral screening

Volume: 102, Issue: 5
Published: May 27, 2021
Abstract
The severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) virus, which is highly pathogenic and classified as a biosafety level 3 (BSL-3) agent, has greatly threatened global health and efficacious antivirals are urgently needed. The high requirement of facilities to manipulate the live virus has limited the development of antiviral study. Here, we constructed a reporter replicon of SARS-CoV-2, which can be handled in a BSL-2 laboratory....
Paper Details
Title
SARS-CoV-2 replicon for high-throughput antiviral screening
Published Date
May 27, 2021
Volume
102
Issue
5
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.